Siltari, A. (2023) “Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish me”, Acta Oncologica, 62(12), pp. 1898–1904. doi: 10.1080/0284186X.2023.2278189.